Anna Bryson sold $5.6M of DOCS
Chief Financial Officer at Doximity, Inc.. 95,000 shares at an average of $58.69, traded May 1, 2025, filed May 2, 2025.
Score components
- +22RoleCFO
- +25Trade size$5.6M at market
- +5Share of holdings soldSold 24% of holdings
- +8Cluster2 insiders selling within 14 days
- -15Exercise and sellShares came from an option exercise in the same filing
- -2010b5-1 planPre-scheduled under a 10b5-1 plan
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001516513-25-000040, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| May 1, 2025 | CConversion Class A Common Stock10b5-1 | +45,000 | - | - | 402,165 | May 2, 2025 |
| May 1, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -22,241 | $56.80 | $1.3M | 379,924 | May 2, 2025 |
| May 1, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -22,759 | $57.65 | $1.3M | 357,165 | May 2, 2025 |
| May 2, 2025 | CConversion Class A Common Stock10b5-1 | +50,000 | - | - | 407,165 | May 2, 2025 |
| May 2, 2025 | SOpen-market sale Class A Common Stock10b5-1 | -50,000 | $60.00 | $3.0M | 357,165 | May 2, 2025 |
| May 1, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -45,000 | $0.00 | $0 | 337,268 | May 2, 2025 |
| May 1, 2025 | MOption exercise Class B Common Stockderivative10b5-1 | +45,000 | $0.00 | $0 | 45,000 | May 2, 2025 |
| May 1, 2025 | CConversion Class B Common Stockderivative10b5-1 | -45,000 | $0.00 | $0 | 0 | May 2, 2025 |
| May 2, 2025 | MOption exercise Stock Option (Right to Buy)derivative10b5-1 | -50,000 | $0.00 | $0 | 287,268 | May 2, 2025 |
| May 2, 2025 | MOption exercise Class B Common Stockderivative10b5-1 | +50,000 | $0.00 | $0 | 50,000 | May 2, 2025 |
| May 2, 2025 | CConversion Class B Common Stockderivative10b5-1 | -50,000 | $0.00 | $0 | 0 | May 2, 2025 |
Related signals
Other insiders at Doximity, Inc. and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 0Weak | Doximity, Inc. | Kira Scherer Wampler director | $58k 2,000 shares | -7% | |
| 9Weak | Doximity, Inc. | Watkin Phoebe L. Yang director | $34k 1,290 shares | -5% | |
| 0Weak | Doximity, Inc. | Siddharth Sitaram Chief Accounting Officer | $54k 2,077 shares | -2% | |
| 0Weak | Doximity, Inc. | Kira Scherer Wampler director | $53k 2,000 shares | -7% | |
| 33Weak | Doximity, Inc. | Timothy S Cabral director | $1.5M 20,000 shares | -86% | |
| 15Weak | Doximity, Inc. | Regina M. Benjamin director | $353k 5,000 shares | -20% | |
| 46Moderate | Doximity, Inc. | Timothy S Cabral director | $422k 6,360 shares | -66% | |
| 6Weak | Doximity, Inc. | Kira Scherer Wampler director | $133k 2,000 shares | -9% | |
| 32Weak | Doximity, Inc. | Anna Bryson Chief Financial Officer | $2.7M 40,000 shares | -10% | |
| 40Moderate | Doximity, Inc. | Timothy S Cabral director | $1.3M 20,000 shares | -76% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.